Induction of CXCL10 secretion by interferon-γ and tumour necrosis factor-α and its inhibition by peroxisome proliferator-activated receptor-γ agonists in cultured scleroderma fibroblasts.
Antonelli
A
A
Ferri
C
C
Ferrari
S M
SM
Colaci
M
M
Giuggioli
D
D
Fallahi
P
P
D000328:Adult; D000368:Aged; D054357:Chemokine CXCL10 / Q000037:antagonists & inhibitors / Q000378:metabolism*; D005260:Female; D005343:Fibrinolytic Agents / Q000494:pharmacology*; D005347:Fibroblasts / Q000187:drug effects* / Q000276:immunology; D006801:Humans; D007371:Interferon-gamma / Q000494:pharmacology*; D008297:Male; D008875:Middle Aged; D047495:PPAR gamma / Q000819:agonists*; D000077154:Rosiglitazone; D012595:Scleroderma, Systemic / Q000276:immunology*; D045162:Thiazolidinediones / Q000494:pharmacology; D014409:Tumor Necrosis Factor-alpha / Q000494:pharmacology*
D054357:Chemokine CXCL10; D005343:Fibrinolytic Agents; D047495:PPAR gamma; D045162:Thiazolidinediones; D014409:Tumor Necrosis Factor-alpha; D000077154:Rosiglitazone; D007371:Interferon-gamma